Iron deficiencies in obstetric-gynecologic practice
DOI: 10.32364/2618-8430-2022-5-2-129-137
Ar.A. Mikhelson, E.Yu. Lebedenko, O.V. Gayda, Al.A. Mikhelson, T.E. Feoktistova, A.M. Mikhelson
Rostov State Medical University, Rostov-on-Don, Russian Federation
Deficiency or excess of microelements and vitamins significantly affects the vital activity at each step of human life. This is particularly significant during pregnancy because of immediate and long-term effects on the fetus and newborn. Iron is one of the essential microelements and plays an important role in the mechanisms of biological oxidation. Iron metabolism in the human body is quite complex and impossible without synergy with other metals and vitamins. Iron is most closely related to folic acid and is critical for many vital processes, including embryogenesis. Considering that iron and folic acid deficiencies (leading to anemias in extreme cases) negatively affect pregnancy course, its favorable outcome, and prognosis for a newborn, these conditions are to be addressed. Medications are diverse, they should be selected based on the specificity of iron and folic acid metabolism. Among preparations currently available in Russia, combined ones best meet the requ irements (iron valence, iron compounds, association with synergid components, dosage form).
Keywords: iron, folic acid, iron-deficiency anemia, folate-deficiency anemia, therapy, combined preparations.
For citation: Mikhelson Ar.A., Lebedenko E.Yu., Gayda O.V. et al. Iron deficiencies in obstetric-gynecologic practice. Russian Journal of Woman and Child Health. 2022;5(2):129–137 (in Russ.). DOI: 10.32364/2618-8430-2022-5-2-129-137.
About the authors:
Artur A. Mikhelson — C. Sc. (Med.), associate professor of the Department of Obstetrics and Gynecology No. 3, Rostov State Medical University; 29, Nakhichevanskiy lane, Rostov-on-Don, 344022, Russian Federation; ORCID iD 0000-0002-8282-2248.
Elizaveta Yu. Lebedenko — Dr. Sc. (Med.), associate Professor, Head of the Department of Obstetrics and Gynecology No. 3, Rostov State Medical University; 29, Nakhichevanskiy lane, Rostov-on-Don, 344022, Russian Federation; ORCID iD 0000-0003-2602-1486.
Oksana V. Gayda — C. Sc. (Med.), associate professor of the Department of Obstetrics and Gynecology No. 3, Rostov State Medical University; 29, Nakhichevanskiy lane, Rostov-on-Don, 344022, Russian Federation; ORCID iD 0000-0002-6966-1793.
Aleksandr A. Mikhelson — C. Sc. (Med.), associate professor of the Department of Obstetrics and Gynecology No. 3, Rostov State Medical University; 29, Nakhichevanskiy lane, Rostov-on-Don, 344022, Russian Federation; ORCID iD 0000-0001-5053-5941.
Tatyana E. Feoktistova — C. Sc. (Med.), associate professor of the Department of Obstetrics and Gynecology No. 3, Rostov State Medical University; 29, Nakhichevanskiy lane, Rostov-on-Don, 344022, Russian Federation; ORCID iD 0000-0003-1591-2013.
Aliya M. Mikhelson — C. Sc. (Med.), obstetrician-gynecologist, Rostov State Medical University; 29, Nakhichevanskiy lane, Rostov-on-Don, 344022, Russian Federation; ORCID iD 0000-0003-1680-8509.
Contact information: Artur A. Mikhelson, e-mail: artur.mikhelson@gmail.com.
Financial Disclosure: no authors have a financial or property interest in any material or method mentioned.
There is no conflict of interests.
Received 04.03.2022.
Revised 31.03.2022.
Accepted 25.04.2022.
2. Kharb S., Aggarwal D., Bala J., Nanda S. Evaluation of homocysteine, vitamin B12 and folic acid levels during all the trimesters in pregnant and preeclamptic womens. Curr Hypertens Rev. 2016;12(3):234–238. DOI: 10.2174/1573402112666161010151632.
3. Peña-Rosas J.P., De-Regil L.M., Garcia-Casal M.N., Dowswell T. Daily oral iron supplementation during pregnancy. Cochrane Database Syst Rev. 2015;2015(7):CD004736. DOI: 10.1002/14651858.CD004736.pub5.
4. McAlpine J.M., Scott R., Scuffham P.A. et al. The association between third trimester multivitamin/mineral supplements and gestational length in uncomplicated pregnancies. Women Birth. 2016;29(1):41–46. DOI: 10.1016/j.wombi.2015.07.185.
5. Li B., Zhang X., Peng X. et al. Folic acid and risk of preterm birth: a meta-analysis. Front Neurosci. 2019;13:1284. DOI: 10.3389/fnins.2019.01284.
6. Pogorelova T.N., Gunko V.O., Nikashina A.A. et al. Violation of the balance of free metals and metal-containing proteins in amniotic fluid in placental insufficiency. Clinical laboratory diagnostics. 2021;66(5):266–270 (in Russ.). DOI: 10.51620/0869-2084-2021-66-5-266-270.
7. Radzinsky V.E., Klimova O.I., Mingaleva N.V. et al. Overcoming the lack of vitamins and minerals as a component of preconception preparation (based on the results of the open observational program "HERA"). StatusPraesens. Gynecology, obstetrics, barren marriage. 2021;3(77):60–65 (in Russ.).
8. Pestrikova T.Yu., Yurasova E.A., Tkachenko V.A. Placental insufficiency as the underlying condition of the complications and outcomes of the gestation period. Russian Bulletin of an obstetrician-gynecologist. 2020;20(1):5–15 (in Russ.). DOI: 10.17116/rosakush2020200115.
9. Berezhnoy V.V., Korneva V.V. Complex approaches to curing teenage deficiencies of iron, zink and vitamins of b group. Modern Pediatrics. 2016;3(75):45–53 (in Russ.). DOI: 10.15574/SP.2016.75.45.
10. Shamov I.A., Gasanova P.O. Iron, absorption, transport. Bulletin of hematology. 2016;12(1):31–38 (in Russ.).
11. Vashchenko V.I., Vashchenko T.N. Ceruloplasmin — from metabolite to drug. Psychopharmacology and biological narcology. 2006;6(3):1254–1269 (in Russ.).
12. Gromova O.A., Rebrov V.G. Iron as a vital nutrient. Effective Pharmacotherapy: Obstetrics, gynecology. 2012;2:46–52 (in Russ.).
13. Roberts H., Bourque S.L., Renaud S.J. Maternal iron homeostasis: effect on placental development and function. Reproduction. 2020;160(4):R65–R78. DOI: 10.1530/REP-20-0271.
14. Dukhanin A.S. Current views on the pharmacological correction of iron deficiency conditions in gynecological practice. Gynecology. 2021;23(4):300–306 (in Russ.). DOI: 10.26442/20795696.2021.4.201064.
15. Lukina E.A., Tsvetaeva N.V., Smetanina N.S. Federal clinical guidelines "Diagnosis and treatment of secondary iron overload". M.; 2014 (in Russ.).
16. Orlov Yu.P., Govorova N.V., Nochnaya Yu.A., Rudnov V.A. Anemia of inflammation: features, the necessity for and possibility of correction (literature review). Alexander Saltanov Intensive Care Herald. 2019;1:20–35 (in Russ.). DOI: 10.21320/1818-474X-2019-1-20-35.
17. Gromova O.A., Torshin I.Yu., Khadzhidis A.K. Adverse effects of iron sulfate in obstetrics, pediatrics and therapeutics. Zemskiy vrach. 2010;2:39–44 (in Russ.).
18. Ermolenko V.M., Filatova N.N. Physiology of iron metabolism. Anemia. 2004;1:3–10 (in Russ.).
19. Yarets Yu.I. Specific proteins: a practical guide for physicians: in 2 parts. Part II. Clinical and diagnostic significance of the determination of specific proteins. Gomel; 2015 (in Russ.).
20. Shahverdieva I.J. Changes of cytokine profile in the blood of pregnant women with anemia. Clinical laboratory diagnostics. 2019;64(8):477–480 (in Russ.). DOI: 10.18821/0869-2084-2019-64-8-477-480.
21. Tutelyan V.A. Vitamins and trace elements in clinical pharmacology. M.: Palea; 2001 (in Russ.).
22. Shaldzhyan A.L., Vartanyan G.S., Saaryan A.V., Agadzhanov M.I. Possible biochemical mechanisms involved in beneficial and adverse effects of folates. Obesity and metabolism. 2016;13(3):9–14 (in Russ.). DOI: 10.14341/OMET201639-14.
23. Irwin R.E., Thursby S.-J., Ondičová M. et al. A randomized controlled trial of folic acid intervention in pregnancy highlights a putative methylation-regulated control element at ZFP57. Clin Epigenetics. 2019;11(1):31. DOI: 10.1186/s13148-019-0618-0.
24. Harrison A., Pentieva K., Ozaki M. et al. Assessment of candidate folate sensitive-differentially methylated regions in a randomised controlled trial of continued folic acid supplementation during the second and third trimesters of pregnancy. Ann Hum Genet. 2019;83(1):23–33. DOI: 10.1111/ahg.12281.
25. Caffrey A., Irwin R.E., McNulty H. et al. Gene-specific DNA methylation in newborns in response to folic acid supplementation during the second and third trimesters of pregnancy: epigenetic analysis from a randomized controlled trial. Am J Clin Nutr. 2018;107(4):566–575. DOI: 10.1093/ajcn/nqx069.
26. Mills J.L., Signore C. Neural tube defect rates before and after food fortification with folic acid. Am Clin Mol Teratol. 2004;70(11):844–845. DOI: 10.1002/bdra.20075.
27. Shikh E.V., Makhova A.A. Benefits of folate status correction using metafolin-contained vitamin-mineral complex. Difficult patient. 2013;9:26–31 (in Russ.).
28. Litwack G. Human Biochemistry (Second Edition). Academic Press, 2022. DOI: 10.1016/B978-0-323-85718-5.00021-2.
29. Pavlovich S.V. Folates: myths and reality. XIII All-Russian Scientific Forum "Mother and Child". Satellite Symposium of Dr. Reddy’s Laboratories Ltd. Gynecology. 2012;5(in Russ.).
30. Larina T.N., Suprun S.V. Folate cycle: pathogenetic mechanisms of pregnancy complications (review). Bull physical and pat breath. 2018;70:113–120 (in Russ.).
31. Mikhelson A.A., Pogorelova T.N., Gunko V.O. et al. Impairments in metabolism of amino acids — precursors of gasotransmitters in the premature birth. Biomedical Chemistry. 2021;67(5):443–448 (in Russ.). DOI: 10.18097/PBMC20216705443.
32. Davydova Yu.V. Folate deficiency and the role of its correction in prevention of obstetric and perinatal complications. Perinatology and Pediatrics Ukraine. 2018;1(73):63–68 (in Russ.). DOI: 10.15574/PP.2018.73.63.
33. Radzinsky V.E., Solovieva A.V., Sturov V.G. et al. Anemia and reproductive health. M.: Editorial staff of StatusPraesens; 2019 (in Russ.).
34. Sorokina A.V. Anemia in pregnancy. Russian Bulletin of an obstetrician-gynecologist. 2015;5:132–137 (in Russ.). DOI: 10.17116/rosakush2015154132-137.
35. Demidova M.A., Malygin A.S. Folate and women’s reproductive health: a modern view on the problem. Obstetrics and gynecology. News. Opinions. Education. 2021;9(33):29–34 (in Russ.). DOI: 10.33029/2303-9698-2021-9-3-29-34.
36. Milman N.T. Dietary iron intake in pregnant women in Europe: a review of 24 studies from 14 countries in the period 1991–2014. J Nutr Metab. 2020;2020:7102190. DOI: 10.1155/2020/ 7102190.
37. Institute of Medicine. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Molybdenum, Nickel, Silicon, Vanadium and Zinc. Food and Nutrition Board. Washington, DC: National Academy Press; 2001.
38. WHO guideline on use of ferritin concentrations to assess iron status in individuals and populations. Geneva: World Health Organization; 2020.
39. Benoist B., McLean E., Egli I., Cogswell M. World Health Organization. Worldwide prevalence of anaemia 1993–2005: WHO global database on anaemia. Geneva, World Health Organization; 2008.
40. Milman N. Prepartum anaemia: prevention and treatment. Ann Hematol. 2008;87:949–959. DOI: 10.1007/s00277-008-0518-4.
41. Medina G.C., León J., Romaní V.A. Maternal anaemia after delivery: prevalence and risk factors. J Obstet Gynaecol. 2018;38:55–59. DOI: 10.1080/01443615.2017.1328669.
42. Auerbach M., Abernathy J., Juul S. et al. Prevalence of iron deficiency in first trimester, nonanemic pregnant women. J Matern Fetal Neonatal Med. 2021;34(6):1002–1005. DOI: 10.1080/14767058.2019.1619690.
43. Choudhury S., Borah A. Activation of NMDA receptor by elevated homocysteine in chronic liver disease contributes to encephalopathy. Med Hypotheses. 2015;85(1):64–67. DOI: 10.1016/j.mehy.2015.03.027.
44. Moretti R. Vitamin D, Homocysteine and Folate in Subcortical Vascular Dementia and Alzheimer Dementia. Front Aging Neurosci. 2017;9:169. DOI: 10.3389/fnagi.2017.00169.
45. Schrott R., Murphy S.K. Folic acid throughout pregnancy: too much? Am J Clin Nutr. 2018;107(4):497–498. DOI: 10.1093/ajcn/nqy055.
46. Zhuchenko L.A. Primary mass prevention of folate-dependent congenital malformations: thesis. M.; 2009 (in Russ.).
47. American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins-Obstetrics. Anemia in Pregnancy: ACOG Practice Bulletin, Number 233. Obstet Gynecol. 2021;1;138(2):e55–e64. DOI: 10.1097/AOG.0000000000004477.
48. Kruglov D.S. The medicines employed for prevention and cure iron deficiency status. Scientific review. Medical Sciences. 2017;4:26–41 (in Russ.).
49. Pavord S., Daru J., Prasannan N. et al. UK guidelines on the management of iron deficiency in pregnancy. Br J Haematol. 2020;188(6):819–830. DOI: 10.1111/bjh.16221.
50. McNulty H., Rollins M., Cassidy T. et al. Effect of continued folic acid supplementation beyond the first trimester of pregnancy on cognitive performance in the child: a follow-up study from a randomized controlled trial (FASSTT Offspring Trial) Randomized Controlled Trial. BMC Med. 2019;17(1):196. DOI: 10.1186/s12916-019-1432-4.
51. Zhu X., Wei L., Cao D. et al. Low serum folate status in the second trimester increase the risk of low birthweight in Chinese women. J Obstet Gynaecol Res. 2018;44(11):2037–2044. DOI: 10.1111/jog.13757.
52. Henry L.-A., Cassidy T., McLaughlin M. et al. Folic Acid Supplementation throughout pregnancy: psychological developmental benefits for children Randomized Controlled Trial. Acta Paediatr. 2018;107(8):1370–1378. DOI: 10.1111/apa.14290.
53. Caffrey A., McNulty H., Rollins M. et al. Effects of maternal folic acid supplementation during the second and third trimesters of pregnancy on neurocognitive development in the child: an 11-year follow-up from a randomised controlled trial. BMC Med. 2021;19(1):73. DOI: 10.1186/s12916-021-01914-9.
54. Clinical guidelines "Iron deficiency anemia". M.; 2021 (in Russ.).
55. Stoffel N.U., Cercamondi C.I. et al. Iron absorption from oral iron supplements given on consecutive versus alternate days and as single morning doses versus twice-daily split dosing in iron-depleted women: two open-label, randomised controlled trials. Lancet Haematol. 2017;4(11):e524–e533. DOI: 10.1016/S2352-3026(17)30182-5.
56. Grekhneva E.V., Kudryavtseva T.N. Features of the use of Eudragit® polymers for the creation of finished dosage forms of biologically active substances. Auditorium. 2020;1(25):8–13 (in Russ.).
57. Expert Council "Iron-deficiency conditions in pregnant women: new combination — new opportunities" Obstetrics and gynecology: news, opinions, training. 2021;9(4):79–82 (in Russ.). DOI: 10.33029/2303-9698-2021-9-4- 79-82.
58. Demina N.B. Current trends in the development of technologies for matrix formulations with modified release (review). Chemical Pharmaceutical J. 2016;50(7):44–50 (in Russ.). DOI: 10.30906/0023-1134-2016-50-7-44-50.
59. Osipyan E.E., Shikh E.V., Drozdov V.N. Prolonged-release technologies: influence on the efficacy and safety of iron formulations. Issues of gynecology, obstetrics and perinatology. 2019;3:149–155 (in Russ.). DOI: 10.20953/1726-1678-2019-3-149-155.
60. Dobrokhotova Yu.E., Markova E.A. Oral long-acting form of iron preparation for the treatment of iron deficiency anemia: clinical review and pharmacoeconomic evaluation. Russian Journal of Woman and Child Health. 2020;3(2):88–94 (in Russ.). DOI: 10.32364/2618-8430-2020-3-2-88-94.
61. Berthumier D., Dupinet P., Tranoy F. Composition with prolonged release of the active substance, method of its preparation and use. Patent No. 2414211 (Electronic resource.) URL: https://patents.google.com/patent/RU2414211C2/ru (access date: 14.02.2022) (in Russ.).
62. Shikh E.V., Makhova A.A. Clinical and pharmacological approaches to the choice of drug for the prevention and treatment of iron deficiency during pregnancy. Pharmacology and Pharmacotherapy. 2021;4:20–27 (in Russ.).
63. Instructions for the medical use of the drug Gino-Tardiferon® (Electronic resource.) URL: https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=e528be41–33a0–4036-a3c3–61f4bc249b46&t= (access date: 14.02.2022) (in Russ.).
This work is licensed under a Creative Commons «Attribution» 4.0 License.
Распечатать